Nerve growth factor (NGF)-and ras-induced neuronal dierentiation of PC12 cells is accompanied by expression of transin, a secreted metalloproteinase. Retinoic acid (RA) is known to exert important eects on neural cell proliferation and dierentiation. In this study we have analysed dierent PC12 sublines which express either activated Ras or dominant negative p21 N17 Ras, to evaluate the in¯uence of retinoic acid (RA) on the response of the transin gene to NGF and Ras. There was a good correlation between neurite extension and induction of transin mRNA levels in the dierent subclones. NGF did not induce transin mRNA in cells which do not dierentiate in response to this neurotrophin. In addition, incubation with RA did not detectably increase basal transin mRNA levels, but caused a signi®cant increase in the transin response to NGF or Ras in cells in which these factors induce a neuronal morphology. Sequences contained within 750 base pairs of the 5'¯anking region of the transin gene confer responsiveness to NGF and Ras, but do not mediate the stimulatory eect of RA. In addition, expression of oncogenic Raf increases transin promoter activity in PC12 cells, but a dominant-negative Raf mutant was unable to block NGF-induced transin activity suggesting the existence of a bifurcation downstream of ras in the signaling mechanism leading to transin expression by NGF.
Introduction
PC12 cells, derived from a rat pheochromocytoma, have been used extensively to study neuronal differentiation. In the untreated state, these cells resemble immature adrenal chroman cells. However, upon treatment with NGF, PC12 cells acquire characteristics of sympathetic neurons, including growth arrest, neurite extension and expression of neuronal markers (Greene and Tischler, 1976) .
The products of the ras and raf proto-oncogenes play an important role in signal transduction from the NGF receptors. The serine/threonine kinase Raf acts downstream of Ras and is activated following NGF treatment (Jaiswal et al., 1994; Oshima et al., 1991; Troppmair et al., 1992; Wood et al., 1992) . Furthermore, expression of oncogenic mutant ras or raf in PC12 cells results in neuronal dierentiation (Bar-Sagi and Feramisco, 1985; Noda et al., 1985; Guerrero et al., 1988; Wood et al., 1993) , whereas a dominant inhibitory ras mutant blocks morphological differentiation induced by NGF (SzebereÂ nyi et al., 1990; Kremer et al., 1991) .
Retinoic acid (RA), an endogenous metabolite of vitamin A, is also a potent regulator of growth and dierentiation of neural cells. The actions of RA are mediated by nuclear receptors (RARs and RXRs) which belong to the steroid/thyroid hormone receptors superfamily and act as ligand-inducible transcription factors (for a recent review see Guiguere, 1994; Kastner et al., 1995) . We have recently shown that RA profoundly aects growth and dierentiation of PC12 cells. RA blocks proliferation and produces cell clumping. In addition, RA causes a transient expression of the low anity neurotrophin receptor p75 LNGFR , tyrosine hydroxylase and TGF-b1 genes similar to that observed during NGF-induced neuronal dierentiation (Cosgaya et al., 1996a, b) .
Transin, the rodent version of human stromelysin, is a secreted metalloproteinase that degrades extracellular matrix (ECM) components (Matrisian et al., 1986) . The remodelling of the ECM is required for a variety of physiological and pathological processes such as development, uterine involution, wound healing, tumor invasion, methastasis, angiogenesis or neurite elongation by dierentiating neurons . The expression of the matrix metalloproteinases is tightly regulated by growth factors, hormones, tumor promoters and oncogene products. In ®broblasts transin is induced by EGF and PDGF (Kerr et al., 1988a) or the ras oncogene (LoSardo et al., 1995) , and inhibited by TGF-b1 (Kerr et al., 1988b) , the synthetic glucocorticoid dexamethasone (Kerr et al., 1988a) or retinoic acid (RA) (Nicholson et al., 1990) . Although an increased transin expression is normally associated with oncogenic transformation and growth factorinduced proliferation , it has been shown that NGF induction of transin accompanies neuronal dierentiation in PC12 cells. The time course of transin induction by NGF is largely coincident with the initial appearance of neurites in these cells (Machida et al., 1989) . Neurite outgrowth induced by Ras or Raf in this cell type is also accompanied by large increases in transin expression .
Several DNA elements in the transin promoter appear to be important for basal and regulated transin gene expression. This promotor contains an AP-1 element which could, at least partially, mediate the action of several growth factors in transin expression in ®broblasts (Kerr et al., 1988a (Kerr et al., , 1990 (Kerr et al., , 1992 . Transcriptional interference with the AP-1 site appear to be responsible for negative regulation by retinoic acid (RA) in this cell type (Nicholson et al., 1990) . In addition, the transin promoter is eciently activated by c-Ets through two DNA binding elements which could play a role in promoter activation by the oncoproteins Ha-Ras, v-Src and v-Mos (Wasylyk et al., 1991) . Similarly, the promoter of other metalloprotease, collagenase, may be regulated by a combination of cEts and AP-1 (Gutman and Wasylyk, 1990) .
In contrast to these results in ®broblasts, the AP-1 site does not seem to be involved in NGF regulation of transin in PC12 cells. Instead, a novel responsive element, which bears no sequence homology to other known transcriptional elements, appears to be necessary for NGF induction of the transin gene (deSouza et al., 1995) . In PC12 cells the NGF induction of transin mRNA was mimicked by activated forms of Src, Ras, or Raf, and is blocked by a dominant inhibitory form of Ras (D'Arcangelo and . From these results, it has been suggested a model in which a linear signaling cascade of activities beginning with the Trk-containing NGF receptor and including a sequence of Src, Ras and Raf proteins, ultimately leads to transin expression and neurite outgrowth . However, no studies on the regulation of transin promoter activity by either the activated or dominant inhibitory forms of the oncogenes have been reported. In this study we have analysed transin gene expression in response to NGF, Ras and RA in several subclones of PC12 cells which express either activated ras or dominant negative Ha-ras
Asn17
. Our results show a good correlation between the development of a morphologically neuronal phenotype and induction of transin expression, con®rming an association between transin expression and neurite elongation. We also show that in PC12 cells RA do not decrease transin mRNA or promoter activity, but rather cooperates with NGF and Ras increasing transin mRNA levels. In addition, although both Ras and Raf increase transin promoter activity in PC12 cells, only a dominant negative Ras, but not a dominant negative Raf mutant was able to block NGF-induced transin activity suggesting the existence of a bifurcation downstream of ras in the signaling mechanism leading to transin expression by NGF. Originally, transin mRNA induction was described to reach a peak after 24 ± 72 h incubation with NGF (Machida et al., 1989) . However, as shown in Figure  1b , we observed a maximal induction after 8 ± 10 h of incubation of PC12 cells with NGF, declining at 24 h and becoming undetectable at 72 h. This time-course is similar to that described in a more recent report and occurred in cells incubated in the presence of either 15% serum or 0.5% serum. In contrast to the NGF-induction found in parental PC12 cells, transin mRNA remained undetectable in UR61 cells treated for 14 h with NGF ( Figure 1a ). The lack of response to NGF was con®rmed in additional experiments performed in UR61 cells at times ranging between 4 h and 6 days and under dierent serum conditions (data not shown).
The absence of transin response to NGF in these cells correlates with the morphological unresponsiveness to the neurotrophin. NGF did not elicit neurite outgrowth in UR61 cells (Figure 1c ), whereas the factor caused extensive morphological dierentiation in parental PC12 cells. There was the possibility that UR61 cells do not respond to NGF because they lack functional receptors. However, UR61 cells express transcripts for trk and for the low anity NGF receptor, p75, at similar levels to those found in PC12 cells (Figure 2a ). In addition, UR61 cells show a normal induction of c-fos mRNA by NGF (Figure 2b ). This mRNA was undetectable in the absence of NGF, but rapidly increased to a signi®cant level 30 min after NGF stimulation. Thereafter, c-fos mRNA decreased rapidly, being barely detectable at 2 h. NGF stimulation in the presence of cycloheximide leads to superinduction of c-fos mRNA and under these conditions reaches the highest levels at 2 h. The levels of c-fos induction were similar in UR61 and PC12 cells in dierent experiments performed, thus showing that the c-fos response is unaltered in UR61 cells which, however, do not dierentiate or show transin induction in response to NGF.
In¯uence of retinoic acid on the induction of transin mRNA by NGF and Ras RA has been shown to repress transin gene expression in polyomavirus-transformed ®broblasts (PyT21) through transcriptional interference with the AP-1 binding site in the promoter (Nicholson et al., 1990) . Since RA blocks proliferation and initiates a biochemical program of neuronal dierentiation in PC12 cells (Scheibe and Wagner, 1992; Cosgaya et al., 1996a) , the in¯uence of RA on transin mRNA levels in control PC12 cells and in cells incubated for 8 h with NGF or phorbol esters was examined ( Figure 3 ). Treatment with NGF increased transin mRNA levels, whereas basal transin mRNA levels remained undetectable in PC12 cells incubated with RA for 8 or 48 h. RA did not reduce the abundance of transin transcripts in NGF-treated PC12 cells, but rather signi®cantly increased the response to the neurotrophin. Eight hours of treatment with TPA also produced a strong induction of transin transcripts and, in contrast with the response to NGF, this induction was repressed by RA. These results support the hypothesis that the eect of NGF and PKC on transin gene expression occur by independent mechanisms.
UR61 cells contain a transfected ras oncogene under control of the inducible MMTV promoter (Guerrero et al., 1988; Thompson et al., 1990) and incubation with dexamethasone induces neurite extension (Figure 4c ). Since the ras gene is involved in the action of NGF in PC12 cells, we examined the eect of activated Ras on transin gene expression in UR61 cells. Figure 4a shows that dexamethasone caused a strong induction of transin mRNA in these cells. The induction was analogous to that produced by NGF in the parental PC12 cells, although the kinetics were slower. A signi®cant increase in transin mRNA was barely detectable before 24 h of incubation with dexamethasone, and a further induction was found at 48 and 72 h. This stimulation was preceded by expression of the ras transcript that was already maximal after 4 h of treatment with the glucocorticoid and was sustained by at least 48 h (Figure 4a , lower panel). Since dexamethasone treatment of PC12 cells did not elevate transin mRNA levels (Figure 4b ), these results indicate that activated Ras is responsible for stimulation of transin gene expression by the steroid in UR61 cells. The in¯uence of RA on transin gene expression in UR61 cells expressing activated ras was also analysed. Basal transin mRNA levels remained undetectable in UR61 cells incubated with RA alone (data not shown). However, incubation with RA produced a signi®cant increase in the transin response to dexamethasone (Figure 5a ). In contrast with the eect of RA, NGF did not alter the transin mRNA response to ras. The induction caused by RA was dose-dependent. A detectable increase in the transin response to Ras was found with 1 nM RA, with the half-maximal response being obtained with 5 nM RA. A 3 ± 3.5 fold induction was found with 1 mM RA; however, higher concentrations did not elicit a further increase (Figure 5b) .
To analyse whether a stronger induction of transin correlated with a more extensive neuronal differentiation of UR61 cells expressing Ras, the cells were incubated from dierent time periods with dexamethasone in the presence or absence of 1 mM RA. RA alone did not cause morphological dierentiation of UR61 cells, although it was a potent inhibitor of UR61 cell proliferation. Dexamethasone caused neurite extension and RA did not further induce the strong neurite outgrowth caused by ras (data not shown).
Regulation of transin promoter activity by NGF, RA and activated Ras in PC12 and UR61 cells
To determine whether RA can regulate the response of the transin promoter to NGF and Ras, PC12 and UR61 cells were transiently transfected with the p750TRCAT construct containing a 753-base pairs region of the transin promoter (Kerr et al., 1988a) . Figure 6a shows that NGF induced a strong increase in CAT activity in PC12 cells. Although RA represses the activity of the transin promoter in transformed ®broblasts (Nicholson et al., 1990) , RA did not decrease promoter activity in PC12 cells and, instead, a slight increase ranging from 1.5-to 2.5-fold in dierent experiments was observed. The induction obtained in the presence of NGF plus RA was similar to that observed with NGF alone. Figure 6b illustrates CAT activity obtained in UR61 cells incubated with NGF and RA in the presence or absence of dexamethasone. It has been shown that transiently transfected oncogenic ras stimulates the activity of the p750TRCAT plasmid in ®broblasts . Incubation with dexamethasone, that induces expression of oncogenic ras, strongly stimulated the activity of the p750TRCAT construct in UR61 cells. Whereas NGF causes strong increases of transin promoter activity in PC12 cells, this factor produced a weaker activation (less than threefold) in UR61 cells. This is in agreement with the lack of detectable eect of NGF on transin mRNA in UR61 cells shown in Figure 1 . Furthermore, this residual response to NGF was totally abolished in cells expressing the activated ras mutant. In contrast with the potentiation of the transin mRNA response to Ras shown in Figure 5 , RA did not in¯uence the response of the transin promoter to dexamethasone. These results show that the sequences responsible for the Ras but not Raf appears to be required for NGFmediated stimulation of the transin promoter
To determine whether endogenous Ras is required for growth factor stimulated expression of the transin gene, the ability of NGF to increase transin mRNA levels and promoter activity in a PC12 subclone (M-M17-26) which constitutively expresses the dominant inhibitory Ha-ras Asn17 mutant (SzebereÂ nyi et al., 1990) was analysed. NGF does not induce neurite outgrowth in M-M17-26 cells. In agreement with the results previously reported in these cells (SzebereÂ nyi et al., 1990) , the levels of transin transcripts were not detectably stimulated by NGF in M-M17-26 cells. In addition, RA did not induce transin mRNA levels in these cells (not illustrated). Figure 7a shows that in transient transfection assays the transin promoter was weakly stimulated (two-to threefold) by NGF in M-M17-26 cells, whereas NGF increased by more than 10-fold CAT activity in parental PC12 cells. In other PC12 cell subline (GSras DN-1), which are transfected with the dominant inhibitory Ras mutant under control of the MMTV promoter, incubation with dexamethasone signi®cantly decreased, but did not totally abolish, the response to NGF (Figure 7b ). These results show that, although a full transin induction by NGF is dependent on the presence of functional Ras, some response to the neurotrophin is still observed in the absence of the oncoprotein.
The results obtained in cells transfected in a stable manner with oncogenic and dominant negative ras mutants were con®rmed in parental PC12 cells transiently transfected with Ha-ras Val12 and Ha-ras
Asn17
. Figure 8a shows that transient expression of oncogenic ras in PC12 cells caused a strong activation of the transin promoter, similar to that found in UR61 cells incubated with dexamethasone. In the presence of Ras the promoter was maximally stimulated and NGF did not induce a further increase. RA was also ineective in modulating the transin promoter response to Ras in these cells. Transfection with the dominant inhibitory mutant ras blocked the increase caused by activated Ras
Val12
, as well as NGF induction of CAT activity. However, as in the case of the M-M17-26 cells in which the dominant negative ras is stably expressed (see Figure  7) , under transient transfection conditions a residual induction (about twofold) was still observed after expression of the inhibitory Ras mutant in PC12 cells.
Raf is known to act downstream of Ras in many of the transcriptional responses to NGF, and transin mRNA is induced in cells transformed with this oncogene (D'Arcangelo and . Figure  8b shows that expression of oncogenic raf in PC12 cells stimulated the transin promoter, although with less potency than the ras oncogene. As in the case of Ras, the eect of NGF and Raf were not additive. Again, RA was ineective in regulating the response of the transin promoter to NGF or Raf.
To determine the role of endogenous Raf proteins in the regulation of the transin promoter, we also investigated the eect of transient transfection with expression vectors for dominant negative forms of raf on the response of the transin promoter to NGF in PC12 cells. Figure 9a compares the eect of dominant negative Ras and Raf on this promoter. In contrast with the dominant negative Ras that signi®cantly inhibited the response to NGF, the negative inhibitory Raf mutant did not decrease the stimulation of CAT activity by NGF. As a control that the Raf protein is inactivated in cells transfected with dominant negative Raf, we analysed the in¯uence of this plasmid on the induction of the transin promoter by activated Raf. As illustrated in panel b, expression of the mutant protein was able to block the activation caused by oncogenic Raf. Furthermore, we have very recently described that NGF activates the TGF-b1 promoter in PC12 cells by a Ras-and Raf-dependent mechanism (Cosgaya and Aranda, 1996) . In the experiment shown in panel C, the transin and the TGF-b1 promoters were cotransfected alone or in combination with dominant negative Raf. NGF signi®cantly increased the activity of both promoters, and the Raf mutant that did not signi®cantly aect NGF stimulation of the transin promoter, signi®cantly inhibited activation of the TGFb1 promoter.
Discussion
In this study the eects of RA and NGF on transin gene expression in dierent subclones of PC12 cells expressing either oncogenic or dominant inhibitory forms of ras were investigated. It was found a good correlation between transin expression and neurite outgrowth. In parental PC12 cells that rapidly extended neurites upon incubation with NGF, we con®rm that there is a concomitant and strong induction of transin transcripts and transin promoter activity. In contrast, in the PC12 cell subline UR61 which does not dierentiate in response to NGF (Guerrero et al., 1988; and Figure 1 ), the neurotrophin did not detectably increase transin transcripts and only weakly activated the transin promoter. It should be noted that basal levels of transin mRNA are extremely low in PC12 cells, and a weak induction should remain below detection levels. UR61 cells are, however, responsive to NGF. They express levels of NGF receptors similar to those found in PC12 cells, and (a) show a normal c-fos response to the neurotrophin. In this cell line, which is transfected in a stable manner with the activated ras Val12 oncogene under control of the glucocorticoid-inducible MMTV promoter, treatment with dexamethasone causes extensive neurite outgrowth. Although dexamethasone has been described to have antagonistic eects on transin gene induction by NGF in PC12 cells (Machida et al., 1989) , expression of the activated oncoprotein overcomes this inhibitory eect, and the steroid strongly induces transin gene expression in UR61 cells. Our results show that activated oncogenic Ras elicits the induction of transin transcripts in UR61 cells with a time course that is quite dierent from the observed in NGFtreated PC12 cells. The time course of Ras oncoprotein induction by dexamethasone is slow relative to the rapid activation of the endogenous Ras by NGF. This could explain, at least in part, the slower time course of transin gene induction observed in response to dexamethasone in UR61 cells. We have further noted that the oncogenic form of Ras results in a signi®cantly more sustained induction of transin transcripts than does NGF treatment (compare Figures 1 and 5 ). This may imply the existence of negative autoregulatory loops that terminate the responses in the signal transduction pathway elicited by the NGF receptor, which may be lost when the pathway is activated downstream by oncogenic Ras. Alternatively, these dierent time courses may indicate that other pathways that are also activated by the NGF receptor, act in conjunction with ras to induce the transin gene.
RA has been shown to repress transin gene expression in transformed ®broblasts. This process is, at least in part, a primary transcriptional response, requires RA receptor and is directed through the AP-1 binding site in the promoter (Nicholson et al., 1990) . In contrast, our data show that in PC12 cells RA does not antagonize the induction of transin mRNA by NGF. In fact, transin mRNA levels were signi®cantly higher in cells treated with RA plus NGF than in cells treated with NGF alone. Furthermore, we have observed that RA cooperates with Ras to induce transin gene expression in UR61 cells. RA was able to signi®cantly enhance the ras-mediated increase of transin mRNA levels in these cells. Cooperation of both pathways on speci®c gene expression, that must occur by distinct pathways, has not been reported before.
Phorbol esters that activate PKC induce transin expression in PC12 cells (Machida et al., 1991) . In contrast with the results obtained with NGF, RA does not potentiate PKC-mediated induction of transin gene expression in PC12 cells. This suggests that NGF and phorbol esters activate the transin gene by dierent mechanisms. In fact, a functional PKC is not required for the action of NGF on transin gene expression in PC12 cells, since removal of endogenous PKC did not prevent the NGF-mediated induction (data not shown). These results are in agreement with a recent report showing that the AP-1 site in the transin promoter does not seem to be involved in regulation by NGF (deSouza et al., 1995) . Further evidence that the AP-1 site is not involved in NGF responsiveness is that c-fos, which binds to this site, is normally induced by NGF in UR61 cells, yet NGF fails to elicit a signi®cant transin induction in these cells.
Previous work from our laboratory has shown that RA closely mimicks in several aspects the eect of NGF on PC12 cells. Thus, both agents induce an arrest of growth, an increase in level of mRNA of low anity neurotrophin receptors, a transient induction of the tyrosine hydroxylase gene (Cosgaya et al., 1996a) and release of TGF-b1 to the medium (Cosgaya et al., 1996b) . This work demonstrates that RA potentiates the eect of NGF or Ras on the transin gene, but does not mimic their eect on basal transin expression. In parallel, RA does not induce neurite extension in PC12 cells (Scheibe et al., 1991; Cosgaya et al., 1996a) . Therefore, although RA could initiate a biochemical program of neuronal dierentiation in PC12 cells, by blocking cell proliferation and regulating the expression of genes also induced by NGF, a fully dierentiated phenotype with transin expression and neurite extension is not obtained.
The transin promoter is activated by NGF and Ras in PC12 cells. To analyse whether or not the sequences responsible for RA induction were present in the promoter fragment that confers responsiveness to NGF and Ras, we also examined the in¯uence of RA in transient transfection assays with the transin promoter. We could not observe a signi®cant regulation of transin promoter activity by RA under any of the conditions analysed. These results show that the sequences responsible for the eect of RA are not contained within the promoter fragment studied. Sequence analysis does not show the presence of a consensus response element (RARE), which could bind the RA receptors and mediate regulation by RA. Therefore, RA-mediated increase of transin mRNA response, involves dierent promoter elements, and possibly dierent transcription factors, from those that mediate the induction of the transin promoter by Ras or NGF. Alternatively, the eect of RA could be not a primary transcriptional response, but rather involve post-transcriptional mechanisms.
The ras proto-oncogene appears to participate in NGF-mediated neurite outgrowth and Raf kinase acts downstream of Ras in the NGF signal transduction cascade. To better understand the signaling pathway in transin induction by NGF, we investigated the eect of its constitutive stimulation by activated oncoproteins on basal transin promoter activity, as well as on the regulation of NGFmediated transin promoter activation. We found that transfection of PC12 cells with oncogenic ras strongly stimulates the transin promoter in PC12 cells. Our data also show that NGF inducibility is reduced or lost in cells expressing the oncogenic form of ras. These results are similar to those found in ®broblasts transformed by this oncoprotein in which serum inducibility of several immediate early genes is also markedly attenuated (Yu et al., 1993) . Because the impairment of the transcriptional responses in both cases involves oncoproteins that stimulate tyrosine kinase signaling pathways, this attentuation could re¯ect a negative regulatory mechanism acting on signaling pathways normally stimulated by growth factor receptors. It is most likely that NGF or serum no longer induce these pathways because they are already maximally stimulated by the activated oncogenes.
Expression of dominant negative mutants of oncoproteins is used to demonstrate the implication of their normal cellular counterparts in a given cellular response. Stable expression of the dominant inhibitory mutant of ras in M-M17-26 or GSras DN-1 cells, as well as transient expression of dominant negative ras in PC12 cells, markedly reduces the induction of transin promoter activity in response to NGF. These results are in agreement with the ®nding that the induction of transin transcripts is markedly impaired in the PC12 subline 17N-2 which constitutively expresses Ha-ras Asn17 (D'Arcangelo and , and strongly suggest the requirement of functional Ras proteins for a full induction of the transin gene by NGF. However, our data clearly show that some response of the transin promoter to the neurotrophin is observed in cells expressing either stably or transiently the dominant inhibitory ras (see Figures 8 ± 10) . Thus, although our data further con®rm that Ras is involved in transin induction by NGF, they also suggest that other pathways elicited from the NGF receptor, in addition to the proto-oncogene cascade, could contribute to this regulation.
Based in the ®nding that transin mRNA levels were induced in PC12 cells expressing an activated raf oncogene in a stable manner, it has been suggested that Raf acts downstream of Ras in NGF-induced transin gene expression . We have observed a stimulatory eect of oncogenic Raf on transin promoter activity in PC12 cells. However, this eect was much weaker than that caused by Ras or NGF. Our data suggest that this gene may be regulated by signals generated upstream of Raf. In contrast with the data obtained with the dominant negative Ras, the dominant negative Raf did not signi®cantly impair the eect of NGF on the transin promoter. The possibility that the mutant was not expressed in PC12 cells in suciently high levels to totally inactivate the endogenous Raf proteins cannot be ruled out. However, this possibility seems unlikely since the inhibitory mutant was able to block the stimulation of the transin promoter by oncogenic Raf, and under the same conditions the Raf mutant inhibited the response of the TGF-b1 promoter to NGF. These results indicate that endogenous Raf might not be required for transin induction by NGF and suggest the existence of a bifurcation downstream of Ras in the signaling mechanism leading to transin expression by NGF. A very recent report suggests that in the regulation of the human transin gene (stromelysin-1) by PDGF, the signal triggered by this growth factor¯ows through Ras and bifurcate towards two distinct pathways, one operating through Raf and the other Raf-independent (Kirstein et al., 1996) . The existence of branchpoints o this signaling cascade to speci®c gene induction events, has been suggested to provide for both ampli®cation of signals as well as alternative, complementary routes (D'Arcangelo and .
Materials and methods

PC12 cell cultures
PC12 cells and PC12-derived transfectant lines were cultured in RPMI medium containing 10% donor horse serum (Quality Biological Inc.) and 5% fetal calf serum (Gibco) and incubated with 7S NGF, RA or dexamethasone at the concentrations and for the times indicated in the ®gures. The PC12 subline M-M17-26 was obtained after transfection with the dominant negative mutant Haras Asn17 gene transcribed from the promoter of the mouse metallothionein-1 gene. This subclone constitutively expresses high levels of mutant Ras protein (SzebereÂ nyi et al., 1990) . UR61 cells were derived from PC12 cells following transfection with a plasmid containing the transformant mouse N-ras
Val12 oncogene under control of the dexamethasone-inducible mouse mammary tumor virus (MMTV) promoter (Guerrero et al., 1988) . In GSras DN-1 cells, the same promoter drives the expression of the dominant negative mutant Ha-ras Asn17 (Thomas et al., 1992) .
Cell morphology
Cell morphology was assessed by phase-contrast microscopy with an inverted microscope and pictures were taken with a Nikon-F2 camera at a magni®cation of 2006. For morphology studies, the cells were seeded at an initial density of 10 000 cells/well using 24-well multidishes and treated with the dierent factors as indicated in the corresponding ®gure.
RNA extraction and hybridization
Total RNA was extracted from the cell cultures with guanidine thiocyanate (Chomczynski and Sacchi, 1987) . The RNA was run in 1% formaldehyde-agarose gels and transferred to nylon-nitrocellulose membranes (Nytran) for Northern blot analysis. The RNA was stained with 0.02% methylene blue. The blots were hybridized with the plasmid pTR-1 which contains a 1.6 kb insert of rat transin cDNA (Matrisian et al., 1986) labeled by nick translation, or with cDNA probes for p75 LNGFR (Radeke et al., 1987) , Trk (Loeb et al., 1991) , c-Fos (Curran and Verma, 1984) or N-ras Val12 (Guerrero et al., 1988) labeled by random oligonucleotide priming. Hybridizations were at 428C with 50% formamide and the more stringent wash was at 428C with 0.16SSC-0.1% SDS. Quanti®cation of mRNA levels was carried out by densitometric scan of the autoradiograms. The values obtained were always corrected by the amount of RNA applied in each lane which was determined by densitometry of the stained membranes.
DNA transfection
For transient expression assays the cells were plated 24 h prior to transfection by the calcium phosphate method in 60 mm petri dishes. The cells were transfected with 5 mg of the reporter CAT construct p750TRCAT containing 750 bp transin promoter region (Kerr et al., 1988a) in the presence of 10 mg carrier DNA (high molecular weight calf thymus DNA, Boehringer). After overnight incubation with the calcium phosphate precipitate, the cells were incubated for 48 h with NGF, RA or dexamethasone, and CAT activity determined. Each treatment was performed in triplicate cultures that normally exhibited less than 10 ± 15% variation in CAT activity, and each experiment was repeated at least three times with similar dierences in regulated expression. Constitutive expression vectors for oncogenic Ha-ras Val12 (Ridley and Hall, 1992) and v-raf (Kolch et al., 1991) were also used in transient transfection assays. In these assays 60 mm petri dishes of PC12 cells were co-transfected with the transin reporter construct and the corresponding expression vector. Similar experiments were carried out in PC12 cells transfected with vectors for dominant negative forms of both oncogenes. These vectors contain the dominant inhibitory Ha-ras Asn17 mutant (Feig and Cooper, 1988) or a dominant negative raf lacking the catalytic domain (Kolch et al., 1991) under control of the Rous Sarcoma virus (RSV) promoter. In all experiments the amount of DNA was kept constant by addition of the same amount of an`empty' non coding vector (RSV-0). In one experiment the transin promoter was cotransfected with 5 mg of a luciferase construct which contains the fragment 71072/+578 of the TGF-b1 gene (Cosgaya and Aranda, 1996) , and CAT and luciferase activities were determined in the same samples after 48 h.
